Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Two Versus One Week Breast Radiotherapy (RT) [Phase 3]
A Phase 3 trial comparing two weeks versus one week of breast radiotherapy is currently recruiting. The study investigates whether shorter r…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients [Phase 2]
A Phase 2 clinical trial is evaluating external hypofractionated radiotherapy with a simultaneous integrated boost for early breast cancer; …
-
FDA approval · 2025-07-24FDA Approved: EXEMESTANE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Exemestane from Aurobindo Pharma Limited, authorizing a generic version of Exemestane in the…
-
FDA approval · 2025-07-24FDA Approved: EXEMESTANE — Supplemental Application (Florida Pharmaceutical Products, LLC)
The FDA approved a supplemental application for Exemestane submitted by Florida Pharmaceutical Products, LLC. Exemestane is an aromatase inh…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction [Phase 3]
A Phase 3 trial comparing hypofractionated versus conventional radiation therapy after prosthetic breast reconstruction in breast cancer pat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Increasing Screening for Cancer Using EHR-Nudges [NA]
A completed clinical trial evaluating whether electronic health record nudges can increase cancer screening rates.
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Transcranial Direct Current Stimulation for Cancer-related Cognitive Impairment in Breast Cancer Survivors [NA]
Clinical trial update for a study evaluating transcranial direct current stimulation to address cognitive impairment in breast cancer surviv…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: The Effect of Health Education Conducted Using Two Different Methods on Women's Knowledge of Breast Cancer, Health Beliefs, Mammography Self-Efficacy, and Participation in Screening Programs [NA]
Clinical trial update evaluating two health education methods on women’s knowledge of breast cancer, health beliefs, mammography self-effica…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment
This clinical trial update notes an oral vinorelbine study in patients with advanced breast cancer after two years of prior therapy, focusin…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Symptom Monitoring Using Patient-Report to Improve Medication Use [NA]
This clinical trial update describes an ongoing study evaluating symptom monitoring using patient-reported outcomes to improve medication us…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: BAriaTric Surgery After Breast Cancer Treatment (BATS) [NA]
This entry provides a status update for the BAriaTric Surgery After Breast Cancer Treatment (BATS) trial. The study is currently not yet rec…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast Cancer [Phase 2]
A Phase 2 clinical trial comparing HB1801 with Taxotere (docetaxel) in advanced breast cancer is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Copenhagen Master Observational Trial
A Copenhagen Master Observational Trial is currently recruiting. It studies patients with non-small cell lung cancer and breast cancer.
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women [NA]
Clinical trial evaluating whether targeted physical activity to address metabolic syndrome can help prevent breast cancer in at-risk women; …
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer Survivors [Phase 2]
The trial status shows completion of a Phase 2 multi-omics study evaluating the effects and mechanisms of acupuncture on psychoneurological …
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Analgesic Effect of Serratus Plane Block With Adjuvant Agents in Breast Cancer Surgery [Phase 2]
This Phase 2 trial update assesses the analgesic effect of serratus plane block with adjuvants in breast cancer surgery.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity [NA]
A clinical trial is evaluating whether sodium-glucose transporter 2 (SGLT2) inhibitors can mitigate anthracycline-related cardiotoxicity in …
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy. [Phase 4]
The GRACE-trial is a phase 4 randomized, active-controlled study evaluating treatment for vulvovaginal atrophy in breast cancer patients on …
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Trial of Exercise to Reduce Cancer Related Fatigue in Breast Cancer [NA]
A trial evaluating whether an exercise program reduces cancer-related fatigue in breast cancer patients has been terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation [NA]
Wake Forest University Health Sciences completed a trial comparing high-dose vitamin D to standard-dose vitamin D supplementation. The liste…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: An Ophthalmic Safety Study in Patients With Breast Cancer
AstraZeneca is conducting an ophthalmic safety study in patients with breast cancer, and the trial is currently recruiting.
-
FDA approval · 2025-07-22FDA Approved: VIJOICE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for VIJOICE (alpelisib) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating the efficacy and safety of the trastuzumab biosimilar Herzuma plus physician's choice in patients with HER2-positiv…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche) [Phase 1]
Phase 1 study comparing pharmacokinetics, immunogenicity, and safety of a trastuzumab biosimilar from Incepta Pharmaceuticals Ltd versus Roc…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer [Phase 1]
A Phase 1 trial evaluating copanlisib in combination with T-DM1 for pretreated unresectable locally advanced or metastatic HER2-positive bre…